Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration
Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Immunology Weekly News - July 30th 2025
🧬 Immunology Updates: Major moves in myasthenia gravis, Crohn’s, psoriasis,…
Respiratory Weekly News - May 16th 2025
Lung & Respiratory Health Breakthroughs: IPF Patient Voices, Asthma Trial…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
Biosimilars: Enhancing physician uptake in the EU
At the moment, EU physicians seem much more comfortable than their US…
The curious case of biosimilar launches in the US
The Biologics Price Competition and Innovation Act (BPCI Act) of 2009 provided…